UMC Guides 10% 2027 ASP Increase Amid Strong Q3 Shipments

What happened

In November 2026, UMC management guided for a 10% year-over-year increase in blended average selling prices for 2027, following Q3 2026 wafer shipments that rose 7.3% sequentially to 1.2 million units. This contrasts with the June 2026 master report's skepticism that pricing power remained unproven after two consecutive years of ASP declines. Strong shipment growth suggests demand is solidifying, but the ASP forecast is a forward-looking expectation rather than realized pricing. Historically, UMC's price increase letters and mix-driven commentary have not immediately translated into company-wide ASP gains. Investors should focus on whether Q4 2026 and early 2027 contract renewals actually deliver higher wafer prices.

Implication

The 10% ASP increase for 2027, if achieved, would exceed the bull case scenario from the master report, which assumed only 3-5% ASP growth in 2026. However, the company's track record shows a gap between price increase announcements and actual realized ASP, as evidenced by 2024-2025 declines despite utilization recovery. Q3 shipment growth of 7.3% is encouraging, but without accompanying ASP data or utilization figures above 85%, the pricing power thesis remains unconfirmed. The next two quarterly reports will be critical: if ASP turns positive and utilization sustains above 85%, the thesis would shift markedly; if not, the stock may have gotten ahead of fundamentals. Investors should monitor the 90-day checkpoint for evidence of 'price increases implemented' rather than mix-driven gains.

Thesis delta

The new guidance for a 10% YoY ASP increase in 2027 introduces a potential upside scenario that was not included in the previous base or bull cases. However, this is a forward-looking statement without supporting data, and UMC has a history of optimistic pricing targets not fully realized. The overall thesis shifts from POTENTIAL SELL to NEUTRAL/WATCH, pending confirmation of real pricing leverage.